Gene · 80339
Papers3,957
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,957
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genome-wide Studies Reveal Genetic Risk Factors for Hepatic Fat Content. | Genomics Proteomics Bioinformatics | 2024 | 39142818 | PubTator, text mining | PubMed |
| Metabolomics biomarkers of hepatocellular carcinoma in a prospective cohort of patients with cirrhosis. | JHEP Rep | 2024 | 39139459 | PubTator, text mining | PubMed |
| The Outcome of Metabolic and Bariatric Surgery in Morbidly Obese Patients with Different Genetic Variants Associated with Obesity: A Systematic Review. | Nutrients | 2024 | 39125390 | PubTator, text mining | PubMed |
| Phase 1 Trials of PNPLA3 siRNA in I148M Homozygous Patients with MAFLD. | N Engl J Med | 2024 | 39083780 | PubTator, text mining | PubMed |
| TM6SF2 E167K variant decreases PNPLA3-mediated PUFA transfer to promote hepatic steatosis and injury in MASLD. | Clin Mol Hepatol | 2024 | 39054606 | PubTator, text mining | PubMed |
| Lifestyle and genetic risk of chronic liver disease in metabolically healthy and unhealthy individuals from the general population. | JHEP Rep | 2024 | 39049959 | PubTator, text mining | PubMed |
| Genotypic variation in CYP2E1, GCKR, and PNPLA3 among nonalcoholic steatohepatitis patients of Turkish origin. | Mol Biol Rep | 2024 | 39042259 | PubTator, text mining | PubMed |
| Combination of risk alleles of PNPLA3, TM6SF2, and HSD17B13 of donors can predict recurrence of steatotic liver disease after liver transplantation. | Hepatol Res | 2024 | 39031833 | PubTator, text mining | PubMed |
| A Comprehensive Investigation of Dietary Micronutrient Intakes and Risk of Alcoholic Liver Disease. | J Nutr | 2024 | 39025330 | PubTator, text mining | PubMed |
| Insulin resistance is an integral feature of MASLD even in the presence of PNPLA3 variants. | JHEP Rep | 2024 | 39022386 | PubTator, text mining | PubMed |
| A PNPLA3-Deficient iPSC-Derived Hepatocyte Screen Identifies Pathways to Potentially Reduce Steatosis in Metabolic Dysfunction-Associated Fatty Liver Disease. | Int J Mol Sci | 2024 | 39000384 | PubTator, text mining | PubMed |
| PNPLA3 I148 M genetic variant in autoimmune hepatitis characterises advanced disease at diagnosis and reduced survival free of cirrhotic events and liver-related mortality. | J Transl Autoimmun | 2024 | 38974691 | PubTator, text mining | PubMed |
| Clinical and genetic risk factors for progressive fibrosis in metabolic dysfunction-associated steatotic liver disease. | Hepatol Commun | 2024 | 38967582 | PubTator, text mining | PubMed |
| Does Genetic Variation in PNPLA3, TM6SF2 and HSD17B13 have a Role in the Development or Prognosis of Hepatocellular Carcinoma in Turkish Patients with Hepatitis B? | J Gastrointestin Liver Dis | 2024 | 38944871 | PubTator, text mining | PubMed |
| Distinct Gut Microbial Signature and Host Genetic Variants in Association with Liver Fibrosis Severity in Patients with MASLD. | Nutrients | 2024 | 38931155 | PubTator, text mining | PubMed |
| Are transmembrane 6 superfamily member 2 gene polymorphisms associated with steatohepatitis after pancreaticoduodenectomy? | JGH Open | 2024 | 38919271 | PubTator, text mining | PubMed |
| Profile of Jonathan C. Cohen. | Proc Natl Acad Sci U S A | 2024 | 38913895 | PubTator, text mining | PubMed |
| Fibroblast growth factor 21 is a hepatokine involved in MASLD progression. | United European Gastroenterol J | 2024 | 38894596 | PubTator, text mining | PubMed |
| Heterocyclic Amines Disrupt Lipid Homeostasis in Cryopreserved Human Hepatocytes. | Cardiovasc Toxicol | 2024 | 38851663 | PubTator, text mining | PubMed |
| LNCHC directly binds and regulates YBX1 stability to ameliorate metabolic dysfunction-associated steatotic liver disease progression. | Liver Int | 2024 | 38847599 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80339/papers?page=19